Provided by Tiger Trade Technology Pte. Ltd.

BriaCell Therapeutics Corp.

3.75
-0.1400-3.60%
Post-market: 3.860.1100+2.93%19:40 EDT
Volume:312.49K
Turnover:1.18M
Market Cap:27.19M
PE:-0.19
High:4.00
Open:3.90
Low:3.72
Close:3.89
52wk High:98.20
52wk Low:3.60
Shares:7.25M
Float Shares:6.48M
Volume Ratio:1.97
T/O Rate:4.82%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-19.9792
EPS(LYR):-62.1862
ROE:-179.21%
ROA:-89.44%
PB:0.88
PE(LYR):-0.06

Loading ...

BriaCell to present four posters at the 2026 AACR

TIPRANKS
·
Mar 18

BriaCell to Present Positive Clinical Data for Bria-IMT™ and Preclinical Data for Next Generation Bria-OTS+™ Personalized Immunotherapy at the 2026 AACR Conference

GlobeNewswire
·
Mar 18

BriaCell to Present Four Poster Presentations at the 2026 AACR Annual Meeting

GlobeNewswire
·
Mar 10

BriaCell Shareholders Approve Auditors and Reelect Board

TIPRANKS
·
Mar 10

BriaCell Shareholders Overwhelmingly Back Board and Auditors at Annual Meeting

TIPRANKS
·
Mar 06

BriaCell Therapeutics Corp. Announces Results of Shareholder Meeting

GlobeNewswire
·
Mar 06

BriaCell Restructures Soluble CD80 Program via BriaPro Deal

TIPRANKS
·
Feb 21

BriaPro to purchase BriaCell’s license to develop, commercialize sCD80

TIPRANKS
·
Feb 19

BriaCell Therapeutics' Phase 3 Breast Cancer Treatment Trial Gets Fifth DSMB Recommendation to Continue

MT Newswires Live
·
Feb 17

BriaCell says patient images show regression, resolution of metastsized tumors

TIPRANKS
·
Jan 28

BriaCell Highlights Extended >18-47 Months Survival in Phase 2 Metastatic Breast Cancer Patients

GlobeNewswire
·
Jan 27

BriaCell Therapeutics Completes $30 Million Public Offering

TIPRANKS
·
Jan 16

Crude Oil Gains Over 1%; US Retail Sales Rise 0.6% In November

Benzinga
·
Jan 15

US-Listed Shares of Briacell Therapeutics Tumble 55% After Co Prices $30 Mln Public Offering

THOMSON REUTERS
·
Jan 14

Top Premarket Decliners

MT Newswires Live
·
Jan 14

BriaCell Therapeutics Prices $30 Million Public Offering of Stock, Warrants

MT Newswires Live
·
Jan 14

BriaCell Therapeutics Announces Pricing of $30 million Public Offering

GlobeNewswire
·
Jan 14

NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 09:51 AM

Reuters
·
Jan 13

BriaCell Therapeutics trading halted, volatility trading pause

TIPRANKS
·
Jan 13

BriaCell reports sustained complete resolution of lung metastasis in Bria-OTS

TIPRANKS
·
Jan 13